Navigation Links
SIRO Clinpharm and CambReg Ltd Strategic Alliance to Offer Regulatory Services in Europe
Date:8/25/2009

MUMBAI, India and CAMBRIDGE, England, Aug. 25 /PRNewswire/ -- SIRO Clinpharm, a leading Indian MNC CRO, and CambReg Regulatory Services, a UK-based pan-European regulatory services provider, announced today the formation of an exclusive strategic alliance to help companies register their products in the European market.

Unlike the US, Europe is a patchwork of small to medium-sized markets with varying regulatory and economic barriers to entry, including a requirement to register new generic drugs in each EU country. Many EU regulators also require small clinical trials called bridging studies to be conducted before marketing approval is granted. These two factors make the introduction of generic and other products in Europe a complex affair.

"Our alliance with CambReg will go a long way in helping small and midsized companies cut through the regulatory maze in Europe," said Dr. Chetan Tamhankar, Chief Operating Officer of SIRO Clinpharm. "This alliance builds on the strength of our European clinical trial operations and allows us to offer greater value to our clients," he added.

Commenting on the alliance, Karen James, Managing Director of CambReg said, "Often companies have to look for multiple vendors to register their products in Europe. CambReg's Pan - European regulatory expertise coupled with SIRO's abilities to conduct fast paced trials in Europe will provide clients with a one-stop and cost effective solution for their European registration needs."

The alliance will offer full scope regulatory services to companies wishing to register human medicines of any kind including new small molecule or biotech entities, Biologics and Herbals as well as Generics. Services include preparing CTAs, MAAs in eCTD format, PIPs, PUMAs, etc and managing DCP/MRP across the EU as well as consultancy for any issues with regulatory authorities.


'/>"/>
SOURCE SIRO Clinpharm
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
2. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
3. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
4. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
5. Replidyne Provides Strategic Update
6. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
7. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
8. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
9. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
10. Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand
11. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... MOUNTAIN VIEW, Calif., Dec. 14 Alexza Pharmaceuticals, ... has submitted its New Drug Application (NDA) for Staccato® ... (FDA). AZ-004 is an inhalation product candidate being ... with schizophrenia or bipolar disorder. The IND for ... in August 2005. ,, "AZ-004 has delivered a predictable ...
(Date:12/14/2009)... Corgenix Medical Corporation (OTC Bulletin ... of diagnostic test kits, and BG Medicine, ... company, announced today a supply agreement whereby ... in enzyme-linked immunosorbent assay (ELISA) microtiter format ... seeking regulatory clearance in the United States ...
(Date:12/14/2009)... Southridge LLC ("Southridge"), an investment firm that provides ... announce that its affiliated fund has closed a private ... equity financing to Imaging Diagnostic Systems, Inc. (OTCBB: IMDS). ... growth of Imaging Diagnostic Systems, Southridge has paved a ... the field of early breast cancer detection," said Stephen ...
Breaking Medicine Technology:Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2Covering Kids 26 Families with Health Insurance is Goal of Back to School Outreach Campaign 54850 1Covering Kids 26 Families with Health Insurance is Goal of Back to School Outreach Campaign 54850 2New Jersey Surgery Centers Pick Health Informatics Consulting to Implement Patient Electronic Health Record Systems 13630 1New Jersey Surgery Centers Pick Health Informatics Consulting to Implement Patient Electronic Health Record Systems 13630 2Los Gatos Research Introduces Second Generation Liquid Water Isotope Analyzer 13628 1Los Gatos Research Introduces Second Generation Liquid Water Isotope Analyzer 13628 2
... Zevalin as consolidation therapy after remission induction in previously untreated patients ... ... July 22 Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTA: CTIC) announced today ... Administration (FDA) in September to,discuss the possibility of filing a supplemental Biologics ...
... of Oxford Clinical Trial,Service Unit and Epidemiological Studies ... SEAS trial of ezetimibe should be,tested by reviewing ... trials of ezetimibe, and reporting on the overall ... drug,manufacturers., The two hypothesis-testing trials (SHARP and ...
Other Medicine Technology:CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 2Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 3
(Date:12/14/2009)... disease had been treated, hadn,t spread, study finds , , ... reduce the risk of death in male colon cancer ... January 1986, included 668 men who,d been treated for ... that had not spread (nonmetastatic cancer). Every two years, ... any new cancer and disease diagnoses, as well as ...
(Date:12/14/2009)... But the bump in odds is small and shouldn,t ... (HealthDay News) -- Older women who take antidepressants may ... stroke and death compared to women not on the ... can be different from clinical significance," stressed Dr. Jordan ... Medical School, and lead author of a report in ...
(Date:12/14/2009)... Diego School of Medicine and Osaka University in Japan ... damage, including inflammation, fibrosis and cancer. The findings suggest ... works could lead to new insights into the development ... to be a master regulator of liver function," said ... of the UC San Diego School of Medicine. He ...
(Date:12/14/2009)... underdiagnosed, poorly treated and highly stigmatized, according to ... Rubin, M.D., Ph.D. So these Washington University physicians ... , In "Demystifying Psychiatry," Zorumski and Rubin, who ... psychiatric patients and helping patient families, say some ... treatment result from a lack of understanding psychiatry ...
(Date:12/14/2009)... perceived age to physical, mental functioning , , , MONDAY, ... than their age tend to live longer than those ... suggests. , The finding came from research that involved ... given physical and cognitive tests and then had their ... photos and indicated the age they perceived the participants ...
Breaking Medicine News(10 mins):Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3Health News:Looking Younger Than Your Age May Mean Longer Life 2
... N.C., Nov. 29 MedCath Corporation,(Nasdaq: MDTH ) ... the BMO Capital Markets 2007 Focus on Healthcare Conference,held ... Hotel in New York., MedCath,s senior management will ... am ET. The presentation will be web cast live ...
... Varian Medical,Systems (NYSE: VAR ) has ... for a major new hospital in,Portsmouth, England. In ... investment waves of the UK government,s Cancer Plan ... receive four high-energy,Clinac(R) iX linear accelerators equipped with ...
... Foundation(R) Finds Tobacco-Free,States Spend Less on Medicaid, ... nearly $10 billion less within five years if ... released today by the,American Legacy Foundation found that ... costs by 5.6 percent., The report, Saving ...
... (OA) of the hip is a growing problem that ... studies have reported on risk factors for developing OA, ... its prognosis. A new study published in the December ... examined patients with hip pain to determine their disease ...
... (NYSE:,CNO) said today that it has agreed to implement a ... (LTCG) for certain,back-office functions of the long term care business ... year that it was,considering this solution. Under the agreement:, ... call center and the processing ...
... 11:30 am ET, Thursday, Nov. 29, WASHINGTON, Nov. ... AIDS Alliance Fund:, WHAT: A press briefing by ... epidemic update as well as recently issued,proposals by several ... We will discuss what the new estimates of the ...
Other Medicine News:Health News:Varian Image-Guided Treatment Machines Selected for Major New Hospital on South Coast of England 2Health News:Varian Image-Guided Treatment Machines Selected for Major New Hospital on South Coast of England 3Health News:Smokers Cost Medicaid System Nearly $10 Billion 2Health News:Smokers Cost Medicaid System Nearly $10 Billion 3Health News:Identifying patients at high risk for total hip replacement 2Health News:Conseco to Implement Systems and Operational Solution From Long Term Care Group 2Health News:Conseco to Implement Systems and Operational Solution From Long Term Care Group 3Health News:Conseco to Implement Systems and Operational Solution From Long Term Care Group 4Health News:Conseco to Implement Systems and Operational Solution From Long Term Care Group 5
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket....
BonePlast is a fast resorbing, osteoconductive bone void filler. By delivering a high dose of calcium to the operative site, BonePlast helps build new bone during the healing process. Packaged in a c...
LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference....
... Osteon 200R is a resorbable, osteoconductive matrix ... cleared for use in oral maxillofacial procedures ... faster-resorbing Pro Osteon 200R has been FDA ... resorbs and is replaced with bone during ...
Medicine Products: